Medication info
Aprovel Tablets 300 mg (Irbesartan)

Aprovel Tablets 300 mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›300mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Oval, film-coated tablets that are white or almost white, biconvex on both sides with a heart shape engraved on one side and the number "2873" engraved on the other side.
Packaging
30 tablets (10 tablets/blister × 3), 100 tablets/bottle
Approval status
Active

MFDS item code 200701738 · Approved 2007.02.08 · Insurance code 652100880

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: The usual dose is 150 mg of irbesartan orally once daily. If the response is inadequate, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (such as at the start of treatment, in patients on hemodialysis, or in elderly patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is increased, in particular, when this drug is administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this drug at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not required; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not required; however, an initial dose of 75 mg should be considered in patients on hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not required in patients with mild to moderate hepatic impairment, but it is recommended that the dose not exceed 150 mg daily. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy in patients with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. Also, as part of hypertension treatment, it helps prevent and manage the progression of kidney disease in patients with hypertension and type 2 diabetes. Therefore, it is used for blood pressure control and maintaining kidney health.

How to take

Adult dose

1. Essential hypertension Adults: The usual dose is 150 mg of irbesartan orally once daily. If the response is inadequate, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special cases (such as at the start of treatment, in patients on hemodialysis, or in elderly patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be given concomitantly. The effect is increased, in particular, when this drug is administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this drug at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be administered concomitantly to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not required; however, an initial dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not required; however, an initial dose of 75 mg should be considered in patients on hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not required in patients with mild to moderate hepatic impairment, but it is recommended that the dose not exceed 150 mg daily. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm, particularly to the fetus and newborn, during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by women who are pregnant, breastfeeding, or patients with severe liver disease or allergies to this drug or its components. Particularly, patients with a history of angioedema, certain hereditary metabolic disorders, diabetic nephropathy patients, and those taking ACE inhibitors should avoid administration. Elderly patients, those with hyperkalemia, liver disease, and heart disease should use this medication cautiously, as there is a risk of blood pressure dropping too low, requiring attention. This medication generally has many mild side effects, with the most common being upper respiratory infection, headache, muscle pain, dizziness, and fatigue. Rarely, serious adverse reactions such as angioedema, hyperkalemia, renal failure, liver function impairment, hypoglycemia, or rhabdomyolysis may occur, so consult a doctor immediately if unusual symptoms develop. While taking this medication, regular checks of blood pressure, kidney function, and blood potassium levels are essential. Patients with poor kidney or heart function should be particularly cautious. Interactions may occur when combined with other antihypertensives, diuretics, potassium-sparing agents, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), so always consult healthcare providers. Use during pregnancy is prohibited, and if breastfeeding, either the administration should be avoided, or nursing should be discontinued as this medication can pass into breast milk. Safety in children has not been established, so it is best not to use it in pediatric patients. In cases of overdose, symptoms such as hypotension, tachycardia, and bradycardia may occur; immediate medical attention should be sought if symptoms develop. This medication should be stored out of the reach of children, and it is safest to keep it in its original container. Dizziness or fatigue may occur upon administration, so caution is advised when driving or operating machinery. Patients undergoing diabetes treatment must be vigilant for the risk of hypoglycemia and may require adjustments in drug dosage.

Side effects

  • Upper respiratory tract infection
  • sinusitis
  • influenza
  • pharyngitis
  • rhinitis
  • musculoskeletal pain
  • myalgia
  • headache
  • dizziness
  • fatigue
Show 104 more
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal trauma
  • chest pain
  • dyspepsia
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm edema
  • flushing
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia
  • conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • erectile dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle rigidity
  • arthritis
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • hypersomnia
  • mood disorders
  • depression
  • sensory abnormalities
  • tremors
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate disorders
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • otitis
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • weakness
  • dyspepsia
  • headache
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • hepatitis
  • liver function abnormalities
  • renal failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is also advisable to keep it in a dry place below 30 degrees Celsius. Proper storage can help maintain the efficacy of the medication over time.

Appearance and packaging

Appearance

Oval, film-coated tablets that are white or almost white, biconvex on both sides with a heart shape engraved on one side and the number "2873" engraved on the other side.

Package unit

30 tablets (10 tablets/blister × 3), 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.